New, tumour-specific therapy for colorectal cancer patients.
The combination of colectomy and chemotherapy can save up to 50-70 percent of patients with colorectal cancer. Those who do not have that chance, however, often see their cancer come back in the form of metastasis. A new, more precise therapy could prevent these relapses and even remove the need for...
| Published in: | Research'eu results magazine November, 67 (2017). |
|---|---|
| Format: | Article |
| Language: | English |